RxDoctor Payments Data

Madalyn Neuwirth, MD

Surgical Oncology · Valhalla, NYNPI 1255692141

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,795 of the $4,369 with a category attached, or 86.9%. It is spread thinly across 10 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,434, 3.2 times the $771 reported in 2023.

$4,369in general payments, 2019–2025

Across 51 payments — averaging $85.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$819
  • Dilon Technologies, Inc.$763
  • W. L. Gore & Associates, Inc.$749
  • AbbVie$713
  • Medtronic$692
  • Kerecis Limited$187
  • plus $446 from 4 others

What the payments were for

  • Food & beverage$3,79587%
  • Education$57513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,369 in reported general payments places this provider in the 75th percentile of 173 surgical oncology providers in New York.

See all surgical oncology providers in New York

Medicare billing

Part B allowed, 2024
$26,470
Medicare patients
32
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →